Normal pressure hydrocephalus: long-term outcome after shunt surgery

Pujari, S.; Kharkar, S.; Metellus, P.; Shuck, J.; Williams, M. A.; Rigamonti, D.
November 2008
Journal of Neurology, Neurosurgery & Psychiatry;Nov2008, Vol. 79 Issue 11, p1282
Academic Journal
Background/objective: Little is known about the long-term clinical course and management of patients with normal pressure hydrocephalus (NPH) treated by cere-brospinal fluid (CSF) shunting. Methods: We retrospectively reviewed records of 55 patients diagnosed with idiopathic NPH (INPH) and treated with CSF shunts, all of whom were followed for more than 3 years after the original shunt surgery. At each annual follow-up visit, the patient was assessed by Folstein Mini Mental State Examination, detailed clinical evaluation of gait and assessment of headache, cognition, gait or urination, as assessed by the patient and relatives. Results: The mean duration of follow-up was 5.9 ± 2.5 years. There was an overall sustained improvement among all symptoms. Gait showed the highest maintenance of improvement over baseline (83% at 3 years and 87% at the last analysed follow-up of 7 years), cognition showed intermediary improvement (84% and 86%, respectively), and urinary incontinence showed the least improvement (84% and 80%, respectively). Fifty-three percent of patients required shunt revisions. Indications for revision included shunt malfunction (87%), infection (10%) and change of shunt configuration (3%). Overall, 74% revisions resulted in clinical improvement. Conclusions: Clinical improvement of patients with NPH can be sustained for 5-7 years in some patients with NPH, even if shunt revision surgery is needed multiple times. With earlier diagnosis and treatment of NPH and the increasing lifespan of the ageing population, the need for long-term follow-up after shunt surgery for NPH may be greater than it was in the past. Monitoring, identification and treatment of shunt obstruction is a key management principle.


Related Articles

  • Evolution of surgical interventions for hydrocephalus: patient preferences and the need for proper information. Eghwrudjakpor, O.; Allison, A. B. // Internet Journal of Medical Update;Jul2010, Vol. 5 Issue 2, p55 

    The treatment of hydrocephalus has undergone remarkable transformation since it was first documented over two thousand years ago. Currently, the focus of hydrocephalus research is on minimally invasive techniques of treatment. This article reviews the evolution of hydrocephalus therapy, and...

  • Endoscopic third ventriculostomy in tuberculous meningitis needs more evidence. Misra, Usha K.; Kalita, J.; Prabhakar, S.; Chakravarty, A.; Kochar, D.; Nair, P. P. // Annals of Indian Academy of Neurology;Sep2012, Vol. 15 Issue 3, p233 

    A response by UK Misra to a letter to the editor on her article "Cerebral malaria and bacterial meningitis," in the July 2011 issue is presented.

  • A Tale of the Unexpected. Gutierrez, Carolyn // For the Record (Great Valley Publishing Company, Inc.);12/3/2012, Vol. 24 Issue 22, p22 

    The article discusses the causes of hydrocephalus, its treatment technologies and collaboration between the discoverers and Roald Dahl in invention of the therapy. The cerebrospinal fluid defect was primarily treated with ventriculoperitoneal shunts and the alternative Wade-Dahl-Till (WDT)...

  • Treatment of Hydrocephalus Secondary to Cryptococcal Meningitis by Use of Shunting. Park, Matthew K.; Hospenthal, Duane R.; Bennett, John E. // Clinical Infectious Diseases;3/1/1999, Vol. 28 Issue 3, p629 

    Describes the use of cerebrospinal fluid shunting in virus-infected patients with hydrocephalus. Association of hydrocephalus with increased morbidity and mortality in cryptococcal meningitis; Late revision of shunts; Eradication of Cryptococcus organisms; Correlation between resolution of...

  • Management of cranial deformity following ventricular shunting. Doorenbosch, X.; Molloy, C. J.; David, D. J.; Santoreneos, S.; Anderson, P. J. // Child's Nervous System;Jul2009, Vol. 25 Issue 7, p871 

    Ventricular shunt-induced craniosynostosis is a widely recognised cause of secondary craniosynostosis. We reviewed the management and long-term outcome of the cases of cranial deformity post cerebrospinal fluid shunting in our unit and compared these with previously published series. The...

  • Ventriculoperitoneal shunt block: what are the best predictive clinical indicators? Barnes, N.P.; Jones, S.J.; Hayward, R.D; Harkness, W.J.; Thompson, D. // Archives of Disease in Childhood;Sep2002, Vol. 87 Issue 3, p198 

    Aims: To evaluate the predictive value of symptoms, signs, and radiographic findings accompanying presumed ventriculoperitoneal (VP) shunt malfunction, by comparing presentation with operative findings and subsequent clinical course. Methods: Prospective study of all 53 patient referrals to a...

  • RELEASE VALVE. Bjerklie, David // Time International (South Pacific Edition);11/4/2002, Issue 43, p83 

    States that a treatment for hydrocephalus shows promise as a treatment for Alzheimer's disease. Implantation of a catheter behind the ear to drain fluid from the brain; Goal of improving the flow of cerebrospinal fluid in the brain and reducing the buildup of neurotoxic proteins; Indication...

  • RELEASE VALVE. Bjerklie, David // Time;11/4/2002, Vol. 160 Issue 19, p109 

    States that a treatment for hydrocephalus shows promise as a treatment for Alzheimer's disease. Implantation of a catheter behind the ear to drain fluid from the brain; Goal of improving the flow of cerebrospinal fluid in the brain and reducing the buildup of neurotoxic proteins; Indication...

  • Treatment of hydrocephalus with high-pressure valve ventriculoperitoneal shunt in a dog. Jong Min Kim; Jinuk Park; Ji-hye Kim; Tae Sung Han; Dongwoo Chang; Ki-Jeong Na; Seok Hwa Choi; Gonhyung Kim // Japanese Journal of Veterinary Research;Aug2010, Vol. 58 Issue 2, p137 

    The article presents a study on the use of high-pressure valve ventriculoperitoneal shunt to treat hydrocephalus in a 5-month-old male Maltese dog. The study involved the implantation of a ventriculoperitoneal shunt and used an adjustable valve set at 2.5 performance level to drain the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics